Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 19, 2025, Aptose Biosciences (APTO) has a market cap of $4.365 million USD. According to our data, Aptose Biosciences is ranked No.9033 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 19, 2025 | $4.36 M |
-68.47%
|
| Dec 31, 2024 | $13.84 M |
-90.94%
|
| Dec 29, 2023 | $0.15 B |
337.93%
|
| Dec 30, 2022 | $34.91 M |
-57.04%
|
| Dec 31, 2021 | $81.24 M |
-69.18%
|
| Dec 31, 2020 | $0.26 B |
-22.75%
|
| Dec 31, 2019 | $0.34 B |
196.86%
|
| Dec 31, 2018 | $0.11 B |
-14.73%
|
| Dec 29, 2017 | $0.13 B |
61.15%
|
| Dec 30, 2016 | $83.65 M |
-45.06%
|
| Dec 31, 2015 | $0.15 B |
-57.48%
|
| Dec 31, 2014 | $0.36 B |
-4.65%
|
| Dec 31, 2013 | $0.38 B |
73.33%
|
| Dec 31, 2012 | $0.22 B |
66.67%
|
| Dec 30, 2011 | $0.13 B |
-82.35%
|
| Dec 31, 2010 | $0.74 B |
-43.33%
|
| Dec 31, 2009 | $1.30 B |
100.00%
|
| Dec 31, 2008 | $0.65 B |
-83.33%
|
| Dec 31, 2007 | $3.90 B |
-18.18%
|
| Dec 29, 2006 | $4.77 B |
-12.00%
|
| Dec 30, 2005 | $5.42 B |
-58.33%
|
| Dec 31, 2004 | $13.00 B |
-21.05%
|
| Dec 31, 2003 | $16.47 B |
130.30%
|
| Dec 31, 2002 | $7.15 B |
-58.75%
|
| Dec 31, 2001 | $17.33 B |
-30.81%
|
| Dec 29, 2000 | $25.05 B |
29.82%
|
| Dec 31, 1999 | $19.30 B |
470.00%
|
| Dec 31, 1998 | $3.39 B |
-72.22%
|
| Dec 31, 1997 | $12.19 B |
-25.00%
|
| Dec 31, 1996 | $16.25 B |
33.33%
|
| Dec 29, 1995 | $12.19 B |
-40.98%
|
| Dec 30, 1994 | $20.65 B |
-56.43%
|
| Dec 31, 1993 | $47.39 B |
-43.09%
|
| Dec 31, 1992 | $83.28 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 BeiGene
BGNE
|
$20.21 B |
-1.816 B
|
China
|
 Zymeworks
ZYME
|
$0.80 B |
-0.000 M
|
Canada
|
 Array Technologies
ARRY
|
$0.66 B |
0.000 M
|
USA
|
 Exelixis
EXEL
|
$9.97 B |
-0.000 M
|
USA
|
 Cytokinetics
CYTK
|
$4.71 B |
-0.000 M
|
USA
|
 MacroGenics
MGNX
|
$79.49 M |
-0.000 M
|
USA
|
 Iovance Biotherapeutics
IOVA
|
$1.00 B |
-0.000 M
|
USA
|
 Adaptive Biotechnologies
ADPT
|
$1.09 B |
0.000 M
|
USA
|
 Gilead Sciences
GILD
|
$130.32 B |
-0.001 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$100.17 B |
-0.004 M
|
USA
|
 AbbVie
ABBV
|
$306.02 B |
0.008 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
USA
|
 Novartis
NVS
|
$219.89 B |
0.932 B
|
Switzerland
|
| Market Cap | = | APTO Stock Price | * | APTO Shares Outstanding |
| = | $2.08 | * | 2.55 M | |
| = | $4.36 M |